← All Sponsors
SPONSOR

The Ketamine Research Foundation

Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: Phantom Limb Syndrome With Pain

The Ketamine Research Foundation is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Phantom Limb Syndrome With Pain.

The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — The Ketamine Research Foundation

How many clinical trials has The Ketamine Research Foundation sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by The Ketamine Research Foundation, of which 1 are actively recruiting participants. These trials cover conditions including Phantom Limb Syndrome With Pain. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The Ketamine Research Foundation research focus on?
The Ketamine Research Foundation clinical trials span Phantom Limb Syndrome With Pain. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The Ketamine Research Foundation clinical trial?
To participate in a The Ketamine Research Foundation trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The Ketamine Research Foundation trials with current recruitment status updated daily.

Clinical Trials by The Ketamine Research Foundation

NCT07276542 Phase 2, Phase 3
Recruiting

Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.

Phantom Limb Syndrome With Pain
United States View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology